Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers

Wei, S. et al. (2002) Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clinical Cancer Research, 8, pp. 2246-2252.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Brown, Prof Robert
Authors: Wei, S., Chen, C., Strathdee, G., Harnsomburana, J., Shyu, C., Rahmatpanah, F., Shi, H., Ng, S., Yan, P., Nephew, K., Brown, R., and Huang, T.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Clinical Cancer Research

University Staff: Request a correction | Enlighten Editors: Update this record